z-logo
open-access-imgOpen Access
In vitro screening of BTP-Iso on Schistosoma mansoni and its intermediate host Biomphalaria alexandrina
Author(s) -
Amira Taman,
Samar N. El-Beshbishi,
Samia El Bardicy,
Menerva Tadros,
Magda Ayoub,
Basem Mansour,
Serry A. A. El-Bialy
Publication year - 2016
Publication title -
asian pacific journal of tropical disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.208
H-Index - 33
ISSN - 2222-1808
DOI - 10.1016/s2222-1808(16)61162-3
Subject(s) - schistosoma mansoni , snail , schistosomiasis , biology , viral tegument , intermediate host , incubation , biomphalaria , in vitro , toxicology , schistosoma , host (biology) , immunology , helminths , ecology , biochemistry , virology
Objective: To test the effect of benzimidazole-derived compound (compound BTP-Iso) on\udcultured adult Schistosoma mansoni and clean Biomphalaria alexandrina snails.\udMethods: Adult schistosomes were incubated at different concentrations of compound BTP-Iso\udto calculate mortality rate, LC90 and LC50, in addition, tegumental changes were recorded using\udSEM. Clean Biomphalaria alexandrina snails were also incubated with compound BTP-Iso at\udvarious concentrations to report snail mortality.\udResults: Compound BTP-Iso was found to possess potent antischistosomal activities on adult\udworms but no effect was recorded on snail host. At a concentration of 8 µg/mL, mortality rates\udwere 45.8% and 81.0% after 48 h and 72 h incubation, respectively, while 100% mortality was\udrecorded after 48 h incubation at 20.0 µg/mL and after 72 h incubation at 10.0 µg/mL, with LC50\udand LC\ud90 of 6.1 µg/mL and 9.8 µg/mL, respectively. Morphological changes and tegumental\udalternation of treated worms suggested loss of the tegument and its vital functions.\udConclusions: This study provided the evidence for the potential antischistosomal effect of\udcompound BTP-Iso and its possible uses as an alternative chemotherapeutic agent for treatment\udof schistosomiasis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here